Chenopodium botrys Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Family | Chenopodiaceae. |
| Habitat | The Himalaya, from Kashmir to Sikkim. |
| English | Feather Geramium, Jerusalem-Oak. |
| Folk | Jangaddi (Tibbet). Sahanik, Vaastuuka (Ladakh). |
| Action | Stimulant, diuretic, carminative, antispasmodic, emmenagogue, pectoral. Used in asthma, catarrh; diseases of the stomach and liver. Seeds are considered toxic. |
| Taxonomic Cohort | Genus Chenopodium (3 documented species); Family Chenopodiaceae (7 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Chenopodium botrys (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Chenopodiaceae (primary family classification: Chenopodiaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. Within botanical taxonomy, this taxon is cataloged directly under its primary accepted binomial without secondary botanical synonyms. Biogeographically, its documented habitat and ecological distribution span: The Himalaya, from Kashmir to Sikkim.
Across classical and vernacular Indian systems of medicine, Chenopodium botrys is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Feather Geramium, Jerusalem-Oak; in regional Indian folk and vernacular ethnobotany as Jangaddi (Tibbet). Sahanik, Vaastuuka (Ladakh). Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Chenopodium botrys are: Stimulant, diuretic, carminative, antispasmodic, emmenagogue, pectoral. Used in asthma, catarrh; diseases of the stomach and liver. Seeds are considered toxic. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Chenopodium botrys establish the following evidence base: The herb contains flavonoids (including chrysoeriol and quercetin), also several sesquiterpenoids. Betaine is found in all parts of the plant. Fresh herb yields an essential oil; Indian oil is reported to be devoid of ascaridole, the anthelmintic principle.

Botanical Reference 1: Dysphania botrys — Botanical specimen

Botanical Reference 2: Chenopodium botrys — Wikimedia Commons reference

Botanical Reference 3: Chenopodium botrys — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Chenopodium comprises 3 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Chenopodium album (Action: Laxative, anthelmintic against round-and hookworms, blood-purifier…); Chenopodium ambrosioides (Action: Antispasmodic, pectoral, haemostatic, emmenagogue. Employed in treating nervous…). Comparing Chenopodium botrys alongside its congeners in genus Chenopodium highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Chenopodiaceae encompasses 7 documented medicinal species (0.39% of the 1,814-species flora). Other representative medicinal members of Chenopodiaceae include: Chenopodium album (Vaastuuka), Chenopodium ambrosioides (Sugandh-vaastuuka), Kochia indica (Bui-chholi), Salicornia brachiata (Kohlu), Salsola kali (Sarjikaa). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 7 medicinal species of family Chenopodiaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Chenopodium botrys follow the plant-part modalities specified under its therapeutic action (Stimulant, diuretic, carminative, antispasmodic, emmenagogue, pectoral. Used in asthma, catarrh; diseases of the stomach and liver. Seeds are considered toxic), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Chenopodium botrys integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.